|
|
||||||||||
|
J Am Coll Cardiol, 1994; 23:525-532 © 1994 by the American College of Cardiology Foundation |
Mount Sinai Medical Center, New York, New York 10029.
The fast growing and complex field of invasive cardiology offers a host of opportunities and challenges for the clinician. Scientific and technical advances ranging from molecular biology to microtechnology are changing how physicians make decisions concerning treatment of coronary artery disease, myocardial infarction, unstable angina and electrophysiologic dysfunction. The economic impact and ethical implications presented by these developments contribute to the difficulty of achieving optimal therapeutic solutions for individual patients.
This article has been cited by other articles:
![]() |
R. L. Frye, M. M. Brooks, and R. W. Nesto Gap Between Clinical Trials and Clinical Practice: Lessons From the Bypass Angioplasty Revascularization Investigation (BARI) Circulation, April 15, 2003; 107(14): 1837 - 1839. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |